Manipulating the lewis antigen specificity of the cholesterol-dependent cytolysin lectinolysin

Frontiers in Immunology

Volumn 3, Issue NOV, 2012, Pages

  Lawrence, Sara L ^a   Feil, Susanne C ^a   Holien, Jessica K ^a   Kuiper, Michael J ^b   Doughty, Larissa ^a   Dolezal, Olan ^c   Mulhern, Terrence ^d   Tweten, Rodney K ^e   Parker, Michael W ^a,d  

^a ST VINCENT'S INSTITUTE OF MEDICAL RESEARCH   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

^c CSIRO   (Australia)

^d UNIVERSITY OF MELBOURNE   (Australia)

^e UNIVERSITY OF OKLAHOMA COLLEGE OF MEDICINE   (United States)

Author keywords

Cholesterol dependent cytolysins; Lewis antigens; Molecular dynamics simulations; Protein engineering; Surface plasmon resonance; X ray crystallography

Indexed keywords

EID: 84874212973     PISSN: None     EISSN: 16643224     Source Type: Journal    
DOI: 10.3389/fimmu.2012.00330     Document Type: Article

References (31)

1. Bergelt, S., Frost, S., and Lilie, H. (2009). Listeriolysin O as cytotoxic component of an immunotoxin. Protein Sci. 18,1210-1220.
2. CCP4. (1994). Collaborative Computational Project. The CCP4 Suite: programs for protein crystallography. Acta Crystallogr. D Biol. Crystallogr. 50,760-763.
3. Clarke, K., Lee, F. T., Brechbiel, M. W., Smyth, F. E., Old, L. J., and Scott, A. M. (2000a). In vivo biodistribution of a humanized anti-Lewis Y monoclonal antibody (hu3S193) in MCF-7 xenografted BALB/c nude mice. Cancer Res. 60, 4804-4811.
4. Clarke, K., Lee, F. T., Brechbiel, M. W., Smyth, F. E., Old, L. J., and Scott, A. M. (2000b). Therapeutic efficacy of anti-Lewis(y) humanized 3S193 radioimmunotherapyinabreastcancer model: enhanced activity when combined with taxol chemotherapy. Clin. Cancer Res. 6, 3621-3628.
5. Emsley,P.,andCowtan,K. (2004).Coot: model-building tools for molecular graphics. Acta Crystallogr. D Biol. Crystallogr. 60,2126-2132.
6. Farrand, S., Hotze, E., Friese, P., Hollingshead, S. K., Smith, D. F., Cummings, R. D., et al. (2008). Characterization of a streptococcal cholesterol-dependent cytolysin with alewisyandbspecificlectindomain. Biochemistry 47,7097-7107.
7. Feil, S. C., Lawrence, S., Mulhern, T. D., Holien, J. K., Hotze, E. M., Farrand, S., et al. (2012). Structure of the lectin regulatory domain of the cholesterol-dependent cytolysin lectinolysin reveals the basis for its lewis antigen specificity. Structure 20, 248-258.
8. Gowda, R. M.,Ansari,A. W., and Khan, I. A. (2003). Complete endocardial cushion defect (complete atrioventricularcanal)manifestedin adult life by Streptococcus mitis endocarditis of the common atrioventricular valve. Int. J. Cardiol. 89,109-110.
9. Hall, G. E., and Baddour, L. M. (2002). Apparent failure of endocarditis prophylaxis caused by penicillinresistant Streptococcus mitis. Am. J. Med. Sci. 324,51-53.
10. Hotze, E. M., and Tweten, R. K. (2012). Membrane assembly of the cholesterol-dependent cytolysin pore complex. Biochim. Biophys. Acta 1818, 1028-1038.
11. Huang, I. F., Chiou, C. C., Liu, Y. C., and Hsieh, K. S. (2002). Endocarditis caused by penicillin-resistant Streptococcus mitis in a 12-year-old boy. J. Microbiol. Immunol. Infect. 35, 129-132.
12. Kennedy, M. J., Jackson, M. A., and Kearns, G. L. (2004). Delayed diagnosis of penicillin-resistant Streptococcus mitis endocarditis following single-dose amoxicillin prophylaxis in a child. Clin. Pediatr. (Phila.) 43, 773-776.
13. Kitamura, K., Stockert, E., Garin-Chesa, P., Welt, S., Lloyd, K. O., Armour, K. L., et al. (1994). Specificity analysis of blood group Lewis-y (Le(y)) antibodies generatedagainst synthetic and natural Le(y) determinants. Proc. Natl.Acad. Sci. U.S.A.91, 12957-12961.
14. Kubota, T., Kumagai, A., Ito, H., Furukawa, S., Someya, Y., Takeda, N., et al. (2012). Structural basis for the recognition of Lewis antigens by genogroup I norovirus. J Virol. 86, 11138-11150.
15. McPhillips, T. M., McPhillips, S. E., Chiu, H. J., Cohen, A. E., Deacon, A. M., Ellis, P. J., et al. (2002). Blu-Ice and the Distributed Control System: software for data acquisition and instrument control at macromolecularcrystallographybeamlines. J. Synchrotron. Radiat. 9,401-406.
16. Miyake, M., Taki, T., Hitomi, S., and Hakomori, S. (1992). Correlation of expression of H/Le(y)/Le(b) antigens with survival in patients with carcinoma of the lung. N. Engl. J. Med. 327,14-18.
17. Murshudov, G. N., Vagin, A. A., and Dodson, E. J. (1997). Refinement of macromolecular structures by the maximum-likelihood method. Acta Crystallogr. D Biol. Crystallogr. 53, 240-255.
18. Ohkuni, H., Todome,Y., Okibayashi, F., Watanabe, Y., Ohtani, N., Ishikawa, T., et al. (1997). Purification and partial characterization of a novel human platelet aggregation factor in the extracellular products of Streptococcus mitis, strain Nm-65. FEMS Immunol. Med. Microbiol. 17, 121- 129.
19. Otwinowski, Z., and Minor, W. (1997). Processing of X-ray diffraction data collected in the oscillation mode. Methods Enzymol. 276,307-326.
20. Phillips, J. C., Braun, R., Wang, W., Gumbart, J., Tajkhorshid, E., Villa, E., et al. (2005). Scalable molecular dynamics with NAMD. J. Comput. Chem. 26, 1781-1802.
21. Polekhina, G., Giddings, K. S., Tweten, R. K., and Parker, M. W. (2005). Insights into the action of the superfamily of cholesteroldependent cytolysins from studies of intermedilysin. Proc. Natl. Acad. Sci. U.S.A. 102,600-605.
22. Rossjohn, J., Feil, S. C., McKinstry, W. J., Tweten, R. K., and Parker, M. W. (1997). Structure of a cholesterolbinding,thiol-activatedcytolysinand a model of its membrane form. Cell 89,685-692.
23. Rudd, P. M., Morgan, B. P., Wormald, M. R., Harvey, D. J., Van Den Berg, C. W., Davis, S. J., et al. (1997). The glycosylation of the complement regulatory protein, human erythrocyte CD59. J. Biol. Chem. 272, 7229- 7244.
24. Sakamoto, J., Furukawa, K., Cordon-Cardo, C., Yin, B. W., Rettig, W. J., Oettgen, H. F., et al. (1986). Expression of Lewisa, Lewisb, X, and Y blood group antigens in human colonictumorsandnormaltissueand in human tumor-derived cell lines. Cancer Res. 46,1553-1561.
25. Scott, A. M., Geleick, D., Rubira, M., Clarke, K., Nice, E. C., Smyth, F. E., et al. (2000). Construction, production, and characterization of humanized anti-Lewis Y monoclonal antibody 3S193 for targeted immunotherapy of solid tumors. Cancer Res. 60,3254-3261.
26. Westwood, J. A., Murray, W. K., Trivett, M., Haynes, N. M., Solomon, B., Mileshkin, L., et al. (2009). The Lewis-Y carbohydrate antigen is expressed by many human tumors and can serve as a target for genetically redirected T cells despite the presence of soluble antigen in serum. J. Immunother. 32, 292-301.
27. Westwood, J. A., Smyth, M. J., Teng, M. W., Moeller, M., Trapani, J. A., Scott, A. M.,et al. (2005). Adoptive transfer of T cells modified with a humanized chimeric receptor gene inhibits growthofLewis-Y-expressingtumors in mice. Proc. Natl. Acad. Sci. U.S.A. 102,19051-19056.
28. Wheeler, S. F., Rudd, P. M., Davis, S. J., Dwek, R. A., and Harvey, D. J. (2002). Comparison of the N-linked glycans from soluble and GPI-anchored CD59 expressed in CHO cells. Glycobiology 12, 261-271.
29. Wickham, S. E., Hotze, E. M., Farrand, A. J., Polekhina, G., Nero, T. L., Tomlinson, S., et al. (2011). Mapping the intermedilysin-human CD59 receptor interface reveals a deep correspondence with the binding site on CD59 for complement binding proteins C8α and C9. J. Biol. Chem. 286, 20952-20962.
30. Yin, B. W., Finstad, C. L., Kitamura, K., Federici, M. G., Welshinger, M., Kudryashov, V., et al. (1996). Serological and immunochemical analysis of Lewis y (Ley) blood group antigen expression in epithelial ovarian cancer. Int. J. Cancer 65, 406-412.
31. Yuriev, E., Farrugia, W., Scott, A. M., and Ramsland, P. A. (2005). Three-dimensional structures of carbohydrate determinants of Lewis system antigens: implications for effective antibody targeting of cancer. Immunol. Cell Biol. 83, 709-717.